Boston Scientific CorporationBSXNYSE
Loading
Debt to Assets Over TimeFair Value
Percentile Rank43
3Y CAGR-0.2%
5Y CAGR-1.7%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-0.2%/yr
vs -3.9%/yr prior
5Y CAGR
-1.7%/yr
Consistent
Acceleration
+3.7pp
Accelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive growthFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.28 | +0.5% |
| 2024 | 0.28 | +4.7% |
| 2023 | 0.27 | -5.5% |
| 2022 | 0.29 | -2.5% |
| 2021 | 0.29 | -5.4% |
| 2020 | 0.31 | -7.8% |
| 2019 | 0.34 | +0.4% |
| 2018 | 0.33 | +14.3% |
| 2017 | 0.29 | -3.3% |
| 2016 | 0.30 | - |